EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+12.6%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$204M
AUM Growth
+$204M
(+2.9%)
Cap. Flow
-$7.51M
Cap. Flow
% of AUM
-3.68%
Top 10 Holdings %
Top 10 Hldgs %
56.57%
Holding
75
New
19
Increased
12
Reduced
25
Closed
6
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$5.29M |
| 2 |
RDUS
Radius Health, Inc.
RDUS
|
$3.97M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$3.6M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$3.04M |
| 5 |
Sanofi
SNY
|
$3M |
Top Sells
| 1 |
ABLX
Ablynx NV American Depositary Shares
ABLX
|
$9.92M |
| 2 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$9.66M |
| 3 |
The Ensign Group
ENSG
|
$5.73M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$5.19M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$3.78M |
Sector Composition
| 1 | Healthcare | 59.7% |
| 2 | Real Estate | 12.16% |
| 3 | Industrials | 8.94% |
| 4 | Financials | 0.61% |
| 5 | Technology | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QCP
1
DELISTED
Quality Care Properties, Inc.
QCP
| $23.1M | 10.57% | 1,074,080 +43,419 | +4% | +$934K |
|
|
RCM
2
DELISTED
R1 RCM Inc. Common Stock
RCM
| $15.7M | 7.18% | 1,808,076 -101,811 | -5% | -$884K |
|
|
AERI
3
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $15.3M | 7.01% | 226,902 +16,124 | +8% | +$1.09M |
|
|
RDUS
4
DELISTED
Radius Health, Inc.
RDUS
| $13.8M | 6.32% | 468,581 +134,843 | +40% | +$3.97M |
|
5
GSK
GSK
$79.9B
| $10.3M | 4.72% | 252,584 +26,000 | +11% | +$1.06M |
|
|
6
Sanofi
SNY
$121B
| $8.52M | 3.9% | 212,972 +75,000 | +54% | +$3M |
|
|
7
BioMarin Pharmaceuticals
BMRN
$11.2B
| $7.94M | 3.63% | 84,257 +38,257 | +83% | +$3.6M |
|
|
TLGT
8
DELISTED
Teligent, Inc
TLGT
| $7.31M | 3.34% | 2,112,098 +561,715 | +36% | +$1.94M |
|
|
SAGE
9
DELISTED
Sage Therapeutics
SAGE
| $6.79M | 3.11% | 43,401 +19,401 | +81% | +$3.04M |
|
|
ZGNX
10
DELISTED
Zogenix, Inc.
ZGNX
| $6.67M | 3.05% | 150,845 -53,701 | -26% | -$2.37M |
|
11
Alnylam Pharmaceuticals
ALNY
$58.5B
| $6.25M | 2.86% | 63,493 -15,400 | -20% | -$1.52M |
|
|
12
The Ensign Group
ENSG
$9.91B
| $5.96M | 2.72% | 166,080 -159,817 | -49% | -$5.73M |
|
13
Vertex Pharmaceuticals
VRTX
$100B
| $5.92M | 2.71% | 34,822 -10,000 | -22% | -$1.7M |
|
|
ARNA
14
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.85M | 2.68% | 134,151 -86,637 | -39% | -$3.78M |
|
|
15
Sarepta Therapeutics
SRPT
$1.78B
| $5.29M | 2.42% | +40,000 | New | +$5.29M |
|
|
NVRO
16
DELISTED
NEVRO CORP.
NVRO
| $3.78M | 1.73% | 47,279 -13,571 | -22% | -$1.08M |
|
17
Abbott
ABT
$231B
| $2.8M | 1.28% | 45,900 -2,000 | -4% | -$122K |
|
|
ATHN
18
DELISTED
Athenahealth, Inc.
ATHN
| $2.55M | 1.16% | +16,000 | New | +$2.55M |
|
|
TSRO
19
DELISTED
TESARO, Inc.
TSRO
| $2.34M | 1.07% | 52,523 +1,000 | +2% | +$44.5K |
|
20
AnaptysBio
ANAB
$569M
| $2.32M | 1.06% | +32,634 | New | +$2.32M |
|
|
ABMD
21
DELISTED
Abiomed Inc
ABMD
| $2.29M | 1.05% | 5,594 -1,500 | -21% | -$614K |
|
22
Apellis Pharmaceuticals
APLS
$3.48B
| $2.16M | 0.99% | +98,395 | New | +$2.16M |
|
|
ARQL
23
DELISTED
Arqule Inc
ARQL
| $2.07M | 0.95% | +374,320 | New | +$2.07M |
|
24
argenx
ARGX
$43.6B
| $2.02M | 0.92% | 24,384 -11,400 | -32% | -$945K |
|
25
Ascendis Pharma
ASND
$11.8B
| $2M | 0.91% | 30,054 +6,000 | +25% | +$399K |
|